186 related articles for article (PubMed ID: 12648875)
41. [Borderline tumors of the ovary: a multicenter study in 137 patients].
Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
[TBL] [Abstract][Full Text] [Related]
42. A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study.
Sanguedolce F; Indraccolo U; Tortorella S; Nappi L; Rosenberg P; Greco P; Bufo P
Tumori; 2009; 95(1):112-4. PubMed ID: 19366069
[TBL] [Abstract][Full Text] [Related]
43. Peritoneal psammocarcinoma diagnosed by a Papanicolau smear: a case report.
Riboni F; Giana M; Piantanida P; Vigone A; Surico N; Boldorini R
Acta Cytol; 2010; 54(3):311-3. PubMed ID: 20518416
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
[TBL] [Abstract][Full Text] [Related]
45. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
[TBL] [Abstract][Full Text] [Related]
46. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
[TBL] [Abstract][Full Text] [Related]
47. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum.
Hinson SA; Silva EG; Pinto K
Ann Diagn Pathol; 2013 Jun; 17(3):302-4. PubMed ID: 22921726
[TBL] [Abstract][Full Text] [Related]
48. Serous papillary cystadenocarcinoma arising from autografted ovary of the abdominal wall.
Gong W; Cheng H; Yan Q; Huang G; Luo P; Wang Z
Int J Surg Pathol; 2010 Oct; 18(5):398-400. PubMed ID: 19147508
[TBL] [Abstract][Full Text] [Related]
49. Aggressive Serous Peritoneal Psammocarcinoma: a Case Report.
Colonval P; Boven C; Oana M
Acta Chir Belg; 2015; 115(6):426-8. PubMed ID: 26763843
[TBL] [Abstract][Full Text] [Related]
50. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
51. Bilateral micropapillary serous carcinoma of the ovary: a case report.
Gupta R; Singh S; Nigam S
Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
[TBL] [Abstract][Full Text] [Related]
52. Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
Khatib G; Seyfettinoglu S; Guzel AB; Gulec UK; Unlugenc H; Vardar MA
Gynecol Oncol; 2021 Apr; 161(1):97-103. PubMed ID: 33234261
[TBL] [Abstract][Full Text] [Related]
53. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
54. CT findings of primary extra-intestinal gastrointestinal stromal tumor of greater omentum with extensive peritoneal and bilateral ovarian metastases.
Jindal G; Rastogi R; Kachhawa S; Meena GL
Indian J Cancer; 2011; 48(1):135-7. PubMed ID: 21330768
[No Abstract] [Full Text] [Related]
55. Bilateral synchronous high-grade serous carcinoma and clear cell carcinoma in right and left ovaries with immunohistochemical confirmation: an exceptional finding.
Preeti A; Arunachalam KA; Pradeep Y; Mati GM
Indian J Pathol Microbiol; 2014; 57(4):623-5. PubMed ID: 25308023
[TBL] [Abstract][Full Text] [Related]
56. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
57. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
McNally L; Teng NN; Kapp DS; Karam A
Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
[TBL] [Abstract][Full Text] [Related]
58. [Results of cytoreductive surgery for advanced and recurrent ovarian neoplasms and papillary serous carcinomas of the peritoneum].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2004; 43(5):36-8. PubMed ID: 15518283
[TBL] [Abstract][Full Text] [Related]
59. WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report.
Dohi S; Ohno S; Ohno Y; Takakura M; Kyo S; Soma G; Sugiyama H; Inoue M
Anticancer Res; 2011 Jul; 31(7):2441-5. PubMed ID: 21873157
[TBL] [Abstract][Full Text] [Related]
60. Ovarian serous borderline tumors with invasive peritoneal implants.
Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
